COREG CR (carvedilol phosphate) Woodward Patent: 7,268,156 Expiration: Dec 27, 2023 See More … For more information on how DrugPatentWatch […]
Drug Patent Expirations for the Week of December 24, 2023 Read Post »
Annual Drug Patent Expirations for ABILIFY Abilify is a drug marketed by Otsuka and Otsuka Pharm Co Ltd and is
Annual Drug Patent Expirations for ABILIFY+MYCITE+KIT Abilify Mycite Kit is a drug marketed by Otsuka and is included in one
New patent expiration for Otsuka drug ABILIFY MYCITE KIT Read Post »
Annual Drug Patent Expirations for NEXLETOL Nexletol is a drug marketed by Esperion Theraps Inc and is included in one
New patent expiration for Esperion Theraps drug NEXLETOL Read Post »
Annual Drug Patent Expirations for NEXLIZET Nexlizet is a drug marketed by Esperion Theraps Inc and is included in one
New patent expiration for Esperion Theraps drug NEXLIZET Read Post »
Annual Drug Patent Expirations for ADVAIR+HFA Advair Hfa is a drug marketed by Glaxo Grp Ltd and is included in
New patent expiration for Glaxo Grp drug ADVAIR HFA Read Post »
Annual Drug Patent Expirations for FLOVENT+HFA Flovent Hfa is a drug marketed by Glaxo Grp Ltd and is included in
New patent expiration for Glaxo Grp drug FLOVENT HFA Read Post »
Annual Drug Patent Expirations for VENTOLIN+HFA Ventolin Hfa is a drug marketed by Glaxosmithkline and is included in one NDA.
New patent expiration for Glaxosmithkline drug VENTOLIN HFA Read Post »
Annual Drug Patent Expirations for VYNDAMAX Vyndamax is a drug marketed by Foldrx Pharms and is included in one NDA.
New patent expiration for Foldrx Pharms drug VYNDAMAX Read Post »
Get fresh news and insights, drug patent expirations & more…
